Extended Data Fig. 7: Tumour Mutation Burden across the cohort.

Somatic single nucleotide tumour mutation burden (TMB) for each patient and the mean per cancer type (red line), expressed as genome-wide mutations per MB. Ninety-four percent of tumours had low TMB (<10 mutations per MB), consistent with previous reports10.